Looking for ways to measure tumour aggression

Tests show an association between how aggressive a tumour is and the levels of sugar and inflammatory proteins in the blood. Selangor, Malaysia - (ACN Newswire) - Researchers...

Sino Biopharmaceutical Announces 2018 Third Quarterly Results

Profit Attributable to the Group Increased by Approximately 29.9% to Approximately RMB 2,247,477,000 HONG KONG - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the...

OIC Medicines Authorities committed to cooperating toward Safe, Efficacious and Standardized Medicines and Vaccine...

- First Meeting of OIC NMRAs concludes in the Jakarta Declaration JAKARTA - (ACN Newswire) - The heads of National Medicines Authorities (NMRA) from the Organization of Islamic...

Innovent HK IPO gains wide support from international investors; Spearheads in cancer treatment breakthroughs

HONG KONG - (ACN Newswire) - Chinese biologic drug developer Innovent Biologics (Innovent) becomes the 4th pre-revenue biotech firm to list in Hong Kong yesterday. The seven-year-old...

Innovent Biologics Gets Listed Today; Long-term Bullish Performance Anticipated

HONG KONG - (ACN Newswire) - Innovent Biologics , a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong, with trading officially...

Innovent Biologics Gets Listed Today; Long-term Bullish Performance Anticipated

HONG KONG - (ACN Newswire) - Innovent Biologics , a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong, with trading officially commencing today....

Microbiome – The Next Frontier in Medicine

HONG KONG - (ACN Newswire) - Earlier this year the Hong Kong Exchange updated its listing rules to include pre-revenue biotech stocks for the first...

Ascletis Successfully Listed on the Main Board of HKEX

HONG KONG - (ACN Newswire) - Recently, following the official implementation of the revised listing rules by the Hong Kong Stock Exchange (HKEX), the Hong Kong capital...

Ascletis’ NDA for Its All-oral HCV Treatment Accepted by CFDA

Hangzhou and Shaoxing, China - (ACN Newswire) - Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir...

Ascletis-developed Ganovo Acquired Extraordinary Achievement

Ganovo Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association HONG KONG - (ACN Newswire) - Ascletis announced on...